Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma.
Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures.
Three patients (7.3%) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1%) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5%). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures.
Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Sacko O, Lauwers-Cances V, Brauge D, Sesay M, Brenner A, Roux FE (2011) Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery 68:1192–1198. https://doi.org/10.1227/NEU.0b013e31820c02a3 (discussion 1198–1199)
Taylor MD, Bernstein M (1999) Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg 90:35–41. https://doi.org/10.3171/jns.1999.90.1.0035
Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, Lopes M, Mitchell MC, Roche S, Muller JC, Bitar A, Sichez JP, van Effenterre R (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764–778. https://doi.org/10.3171/jns.2003.98.4.0764
Kim SS, McCutcheon IE, Suki D, Weinberg JS, Sawaya R, Lang FF, Ferson D, Heimberger AB, DeMonte F, Prabhu SS (2009) Awake craniotomy for brain tumors near eloquent cortex: correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patients. Neurosurgery 64:836–845. https://doi.org/10.1227/01.NEU.0000342405.80881.81 (discussion 345–836)
Manninen PH, Tan TK (2002) Postoperative nausea and vomiting after craniotomy for tumor surgery: a comparison between awake craniotomy and general anesthesia. J Clin Anesth 14:279–283
Klimek M, Dammers R (2010) Antiepileptic drug therapy in the perioperative course of neurosurgical patients. Curr Opin Anaesthesiol 23:564–567. https://doi.org/10.1097/ACO.0b013e32833e14f2
Komotar RJ, Raper DM, Starke RM, Iorgulescu JB, Gutin PH (2011) Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg 115:483–490. https://doi.org/10.3171/2011.4.JNS101585
van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421–430. https://doi.org/10.1016/S1474-4422(07)70103-5
Kerkhof M, Vecht CJ (2013) Seizure characteristics and prognostic factors of gliomas. Epilepsia 54(Suppl 9):12–17. https://doi.org/10.1111/epi.12437
Chen H, Judkins J, Thomas C, Wu M, Khoury L, Benjamin CG, Pacione D, Golfinos JG, Kumthekar P, Ghamsari F, Chen L, Lein P, Chetkovich DM, Snuderl M, Horbinski C (2017) Mutant IDH1 and seizures in patients with glioma. Neurology 88:1805–1813. https://doi.org/10.1212/WNL.0000000000003911
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshe SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM (2017) Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:522–530. https://doi.org/10.1111/epi.13670
Chang WH, Pei YC, Wei KC, Chao YP, Chen MH, Yeh HA, Jaw FS, Chen PY (2018) Intraoperative linguistic performance during awake brain surgery predicts postoperative linguistic deficits. J Neuro-oncol. https://doi.org/10.1007/s11060-018-2863-z
Quinn TJ, Dawson J, Walters MR, Lees KR (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke 40:3393–3395. https://doi.org/10.1161/STROKEAHA.109.557256
Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Luders H, Pedley TA (2001) ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 42:282–286
Guerrini R, Rosati A, Giordano F, Genitori L, Barba C (2013) The medical and surgical treatment of tumoral seizures: current and future perspectives. Epilepsia 54(Suppl 9):84–90. https://doi.org/10.1111/epi.12450
Ruda R, Bello L, Duffau H, Soffietti R (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro oncology 14(Suppl 4):iv55–i64. https://doi.org/10.1093/neuonc/nos199
Goellner E, Bianchin MM, Burneo JG, Parrent AG, Steven DA (2013) Timing of early and late seizure recurrence after temporal lobe epilepsy surgery. Epilepsia 54:1933–1941. https://doi.org/10.1111/epi.12389
Nossek E, Matot I, Shahar T, Barzilai O, Rapoport Y, Gonen T, Sela G, Korn A, Hayat D, Ram Z (2013) Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg 118:243–249. https://doi.org/10.3171/2012.10.JNS12511
Nossek E, Matot I, Shahar T, Barzilai O, Rapoport Y, Gonen T, Sela G, Grossman R, Korn A, Hayat D, Ram Z (2013) Intraoperative seizures during awake craniotomy: incidence and consequences: analysis of 477 patients. Neurosurgery 73:135–140. https://doi.org/10.1227/01.neu.0000429847.91707.97 (discussion 140)
Szelenyi A, Bello L, Duffau H, Fava E, Feigl GC, Galanda M, Neuloh G, Signorelli F, Sala F (2010) Intraoperative electrical stimulation in awake craniotomy: methodological aspects of current practice. Neurosurg Focus 28:E7. https://doi.org/10.3171/2009.12.FOCUS09237
Uematsu S, Lesser R, Fisher RS, Gordon B, Hara K, Krauss GL, Vining EP, Webber RW (1992) Motor and sensory cortex in humans: topography studied with chronic subdural stimulation. Neurosurgery 31:59–71 (discussion 71–52)
Pouratian N, Cannestra AF, Bookheimer SY, Martin NA, Toga AW (2004) Variability of intraoperative electrocortical stimulation mapping parameters across and within individuals. J Neurosurg 101:458–466. https://doi.org/10.3171/jns.2004.101.3.0458
Szelenyi A, Bello L, Duffau H, Fava E, Feigl GC, Galanda M, Neuloh G, Signorelli F, Sala F, Workgroup for Intraoperative Management in Low-Grade Glioma Surgery within the European Low-Grade Glioma Network (2010) Intraoperative electrical stimulation in awake craniotomy: methodological aspects of current practice. Neurosurg Focus 28:E7. https://doi.org/10.3171/2009.12.FOCUS09237 N )
Sughrue ME, Rutkowski MJ, Chang EF, Shangari G, Kane AJ, McDermott MW, Berger MS, Parsa AT (2011) Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article. J Neurosurg 114:705–709. https://doi.org/10.3171/2010.5.JNS091972
Wang YC, Chuang CC, Tu PH, Wei KC, Wu CT, Lee CC, Liu ZH, Chen PY (2018) Seizures in surgically resected atypical and malignant meningiomas: long-term outcome analysis. Epilepsy Res 140:82–89. https://doi.org/10.1016/j.eplepsyres.2017.12.013
Englot DJ, Berger MS, Barbaro NM, Chang EF (2011) Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 115:240–244. https://doi.org/10.3171/2011.3.JNS1153
Southwell DG, Garcia PA, Berger MS, Barbaro NM, Chang EF (2012) Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 70:1406–1413. https://doi.org/10.1227/NEU.0b013e3182500a4c (discussion 1413–1404)
Kerkhof M, Dielemans JC, van Breemen MS, Zwinkels H, Walchenbach R, Taphoorn MJ, Vecht CJ (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro oncology 15:961–967. https://doi.org/10.1093/neuonc/not057
Stockhammer F, Misch M, Helms HJ, Lengler U, Prall F, von Deimling A, Hartmann C (2012) IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 21:194–197. https://doi.org/10.1016/j.seizure.2011.12.007
Liubinas SV, D’Abaco GM, Moffat BM, Gonzales M, Feleppa F, Nowell CJ, Gorelik A, Drummond KJ, O’Brien TJ, Kaye AH, Morokoff AP (2014) IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia 55:1438–1443. https://doi.org/10.1111/epi.12662
Feyissa AM, Worrell GA, Tatum WO, Mahato D, Brinkmann BH, Rosenfeld SS, ReFaey K, Bechtle PS, Quinones-Hinojosa A (2018) High-frequency oscillations in awake patients undergoing brain tumor-related epilepsy surgery. Neurology 90:e1119–e1125. https://doi.org/10.1212/WNL.0000000000005216
Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshe SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512–521. https://doi.org/10.1111/epi.13709
Frey LC (2003) Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 44:11–17
Kilpatrick CJ, Davis SM, Hopper JL, Rossiter SC (1992) Early seizures after acute stroke. Risk of late seizures. Arch Neurol 49:509–511
Zheng Z, Chen P, Fu W, Zhu J, Zhang H, Shi J, Zhang J (2013) Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study. J Neuro-oncol 114:101–109. https://doi.org/10.1007/s11060-013-1156-9
Biffi A, Rattani A, Anderson CD, Ayres AM, Gurol EM, Greenberg SM, Rosand J, Viswanathan A (2016) Delayed seizures after intracerebral haemorrhage. Brain 139:2694–2705. https://doi.org/10.1093/brain/aww199
Maschio M, Dinapoli L (2012) Patients with brain tumor-related epilepsy. J Neuro-oncol 109:1–6. https://doi.org/10.1007/s11060-012-0867-7
Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893
Lee YJ, Kim T, Bae SH, Kim YH, Han JH, Yun CH, Kim CY (2013) Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review. CNS Drugs 27:753–759. https://doi.org/10.1007/s40263-013-0094-6
Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA (2010) Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 12:165–172. https://doi.org/10.1007/s12028-009-9304-y
Zachenhofer I, Donat M, Oberndorfer S, Roessler K (2011) Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neuro-oncol 101:101–106. https://doi.org/10.1007/s11060-010-0235-4
Eseonu CI, Eguia F, Garcia O, Kaplan PW, Quinones-Hinojosa A (2018) Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy. J Neurosurg 128:1661–1667. https://doi.org/10.3171/2017.1.JNS162913
The authors thank Yuan-Chun Ting, for his assistance in biostatistics. We also thank the work of Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital. This research was supported by the project of Chang Gung Memorial Hospital, Taiwan (Grant No. CMRPG3G0542).
Conflict of interest
The authors declare to have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. There is no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Wang, Y., Lee, C., Takami, H. et al. Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors. J Neurooncol 142, 577–586 (2019). https://doi.org/10.1007/s11060-019-03131-0
- Awake craniotomy